10 Results for "

PKCι

" in MedChemExpress (MCE) Product Catalog:
Products (10)

10 Results for "PKCι" in MCE Product Catalog:

5
5 Cited Publications
Cat. No.: HY-115492
CAS No.: 382605-72-3
Purity:  99.80%
Target:  

PKC

Research Areas:  

Cancer

NSC668394 is a potent ezrin (Thr567) phosphorylation inhibitor, with a Kd of 12.59 μM. NSC668394 inhibit ezrin T567 phosphorylation caused by PKCΙ primarily via their binding to ezrin. NSC668394 can be used to prevent tumor metastasis .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-126146
CAS No.: 2328094-11-5
Purity:  99.60%
Target:  

PKC AMPK

Research Areas:  

Metabolic Disease Cancer

PKC-iota inhibitor 1 is a protein kinase C-iota (PKC-ι) inhibitor with an IC50 value of 0.34 μM. PKC-iota inhibitor 1 can be used for the study of cancer .
loading...
    loading...
Cat. No.: HY-16662
CAS No.: 75629-57-1
Research Areas:  

Cancer

Oncrasin-1 is an RNA polymerase inhibitor. Oncrasin-1 suppresses the phosphorylation of the largest subunit of RNA polymerase II and the expression of intronless reporter genes in sensitive cells. Oncrasin-1 effectively kills various human lung cancer cells with K-Ras mutations. Oncrasin-1 leads to coaggregation of PKCι and splicing factors into megaspliceosomes. Oncrasin-1 induces malfunction in the RNA processing machinery. Oncrasin-1 is an anti-cancer agent and can therefore be studied in research for lung cancer .
loading...
    loading...
Cat. No.: HY-18713
CAS No.: 1438881-19-6
Target:  

PKC ROCK

CRT0066854 is a potent and selective atypical PKC isoenzymes inhibitor. CRT0066854 is against full-length (FL) PKCι, PKCζ, and ROCK-II kinases with IC50 values of 132 nM, 639 nM, and 620 nM, respectively .
loading...
    loading...
Cat. No.: HY-18713A
CAS No.: 2250019-91-9
Target:  

PKC ROCK

Research Areas:  

Neurological Disease

CRT0066854 hydrochloride is a potent and selective atypical PKCs inhibitor. CRT0066854 is against full-length (FL) PKCι, PKCζ, and ROCK-II kinases with IC50 values of 132 nM, 639 nM, and 620 nM, respectively .
loading...
    loading...
Cat. No.: HY-117366
CAS No.: 2083630-26-4
Purity:  ≥99.0%
Target:  

PKC

Research Areas:  

Cancer

PS432 is a PKC inhibitor with IC50s of 16.9 μM (PKCι) and 18.5 μM (PKCζ), respectively. PS432 effectively inhibits the proliferation of non-small cell lung cancer cells (NSCLCs) and tumor growth in mouse xenograft models .
loading...
    loading...
Cat. No.: HY-122858A
Purity:  99.04%
Target:  

PKC

Research Areas:  

Cancer

PKCiota-IN-2 formic is a potent PKCiota (PKC-ι) inhibitor with an IC50 of 2.8 nM. PKCiota-IN-2 formic also inhibits PKC-α and PKC-ε with IC50s of 71 nM and 350 nM, respectively .
loading...
    loading...
Cat. No.: HY-122857
CAS No.: 2230052-97-6
Target:  

PKC

Research Areas:  

Cancer

PKCiota-IN-1 (compound 51) is a potent PKCiota (PKC-ι) inhibitor with an IC50 of 2.7 nM. PKCiota-IN-1 also inhibits PKC-α and PKC-ε with IC50s of 45 nM and 450 nM, respectively .
loading...
    loading...
Cat. No.: HY-122858
CAS No.: 2230055-52-2
Target:  

PKC

Research Areas:  

Cancer

PKCiota-IN-2 (Compound 49) is a potent PKCiota (PKC-ι) inhibitor with an IC50 of 2.8 nM. PKCiota-IN-2 also inhibits PKC-α and PKC-ε with IC50s of 71 nM and 350 nM, respectively .
loading...
    loading...
Cat. No.: HY-183252
CAS No.: 90597-15-2
Research Areas:  

Cancer

ICA-1S is a specific PKC-ι inhibitor. ICA-1S can inhibit MAPK/JNK signaling pathway and downregulate the levels of c-Jun and TNF-α. ICA-1S inhibits the proliferation of breast cancer cells. ICA-1S induces apoptosis of breast cancer cells. ICA-1S can be used in breast cancer-related research .
loading...
    loading...